Drug Interaction Between Etizolam and Metoclopramide

Mechanism of Interaction and Primary Safety Concerns

The American College of Physicians recommends avoiding the combination of etizolam and metoclopramide due to additive central nervous system (CNS) depression, with a significant increase in risk of excessive sedation and drowsiness, respiratory depression, cognitive impairment, and increased fall risk, particularly in elderly patients 1, 2
The combination of etizolam and metoclopramide produces additive sedative effects, with up to 20% of patients experiencing drowsiness, lassitude, and sedation 1, 2

The American Academy of Family Physicians recommends reducing doses of both agents to the minimum effective amount, particularly in elderly or frail patients, and starting with lower etizolam doses (0.25-0.5 mg) rather than standard dosing 1
The American College of Emergency Physicians suggests using metoclopramide at 10 mg maximum rather than higher doses, and limiting duration of metoclopramide to short-term use only (<5 days when possible) 5, 4

The American Society of Anesthesiologists recommends assessing sedation level before and 1-2 hours after administration, monitoring respiratory rate and oxygen saturation, and watching for early signs of extrapyramidal symptoms (EPS) including restlessness, muscle stiffness, or abnormal movements 1, 2, 3, 4

The American Society of Clinical Oncology recommends using ondansetron (4-8 mg) as a preferred alternative to metoclopramide, as it lacks CNS depressant effects and dopamine antagonism 6, 7
The American Academy of Family Physicians suggests considering prochlorperazine (25 mg) as an alternative, but notes that it carries EPS risk and should not be combined with metoclopramide 5, 3

The American College of Emergency Physicians warns against assuming therapeutic doses are safe together, and recommends avoiding the combination in patients with pulmonary insufficiency or sleep apnea, as respiratory depression risk is substantially elevated 1, 2, 9
The American Geriatrics Society recommends avoiding the combination in elderly patients with dementia or Parkinson's disease due to compounded risks of sedation, falls, and EPS 1, 4